Techub News reports that the biopharmaceutical company Synaptogenix (NASDAQ: SNPX) listed on the US stock market has announced the purchase of TAO, with the specific purchase amount undisclosed. This is part of the company's recently announced financial strategy focused on artificial intelligence (AI) and machine learning in the crypto assets sector, and it will select BitGo to provide qualified custody, stake, and trading services for Synaptogenix's TAO assets.
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
Techub News reports that the biopharmaceutical company Synaptogenix (NASDAQ: SNPX) listed on the US stock market has announced the purchase of TAO, with the specific purchase amount undisclosed. This is part of the company's recently announced financial strategy focused on artificial intelligence (AI) and machine learning in the crypto assets sector, and it will select BitGo to provide qualified custody, stake, and trading services for Synaptogenix's TAO assets.